A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial

Thomas J. Povsic, John H. Alexander, Laura H. Aberle et al.|European Heart Journal|2012

Cited by 108